Facilitated By

San Antonio Medical Foundation

News

  • Celcuity Inc (NASDAQ:CELC) Sellers Decreased By 1.47% Their Shorts As Of Mar 22, 2019

    ... San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast ... Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center – Business Wire” with publication date: October 16, 2018.

  • Initial public offerings scheduled to debut next week

    Precision BioSciences - 7.9 million shares, priced $15-$17, managed by JP Morgan/Gold Sachs. Proposed Nasdaq symbol DTIL. Business: Early ...

  • 1.47% Less Celcuity Inc (NASDAQ:CELC) Short Interest

    The titles are as follows: “Biotech startup Celcuity raises $23M in IPO ... San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast ...

  • Celebrating the 50th: UTSA professor Amina Qutub explores brain health in March 26 lecture

    She is currently a member of the joint UTSA/UT Health San Antonio Graduate Group in Biomedical Engineering and the UTSA Brain Health ...

  • Albanian police arrest Indian wanted for money laundering

    Sandesaras and his brother Nitin own the Sterling Biotech company and borrowed $725 million before leaving India. Last year they got Albanian ...